Novel Anticancer Targets and Drug Discovery in Post Genomic Age

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, Iss. 1, 2005-01 ,pp. : 53-63

Bentham Science Publishers

Access to resources Recommend Favorite

The Design and Characterization of a Novel beta-casein Nano-vehicle Loaded with Platinum Anticancer Drug for Drug Delivery

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 6, 2014-01 ,pp. : 892-900

Bentham Science Publishers

Access to resources Recommend Favorite

Translational Regulation as a Novel Mechanism for the Development of Cellular Drug Resistance

By Schmitz J.C.   Liu J.   Lin X.   Chen T-m.   Yan W.   Tai N.   Gollerkeri A.   Chu E.  

Cancer and Metastasis Reviews, Vol. 20, Iss. 1-2, 2001-03 ,pp. : 35-43

Springer Publishing Company

Access to resources Recommend Favorite

Apoptosis inhibitor TRIAP1 is a novel effector of drug resistance

By                

Oncology Reports, Vol. 34, Iss. 1, 2015-01 ,pp. : 415-422

Spandidos Publications

Access to resources Recommend Favorite

Erlotinib: A Targeted Anticancer Drug

By  

Current Cancer Therapy Reviews, Vol. 13, Iss. 1, 2017-08 ,pp. : 3-16

Bentham Science Publishers

Access to resources Recommend Favorite